JP2012502061A5 - - Google Patents

Download PDF

Info

Publication number
JP2012502061A5
JP2012502061A5 JP2011526247A JP2011526247A JP2012502061A5 JP 2012502061 A5 JP2012502061 A5 JP 2012502061A5 JP 2011526247 A JP2011526247 A JP 2011526247A JP 2011526247 A JP2011526247 A JP 2011526247A JP 2012502061 A5 JP2012502061 A5 JP 2012502061A5
Authority
JP
Japan
Prior art keywords
active ingredient
composition
composition according
hours
zein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011526247A
Other languages
English (en)
Japanese (ja)
Other versions
JP5608653B2 (ja
JP2012502061A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/056103 external-priority patent/WO2010028290A1/en
Publication of JP2012502061A publication Critical patent/JP2012502061A/ja
Publication of JP2012502061A5 publication Critical patent/JP2012502061A5/ja
Application granted granted Critical
Publication of JP5608653B2 publication Critical patent/JP5608653B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2011526247A 2008-09-04 2009-09-04 チュアブルな徐放性製剤 Expired - Fee Related JP5608653B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9436308P 2008-09-04 2008-09-04
US61/094,363 2008-09-04
PCT/US2009/056103 WO2010028290A1 (en) 2008-09-04 2009-09-04 Chewable sustained release formulations

Publications (3)

Publication Number Publication Date
JP2012502061A JP2012502061A (ja) 2012-01-26
JP2012502061A5 true JP2012502061A5 (enExample) 2012-09-20
JP5608653B2 JP5608653B2 (ja) 2014-10-15

Family

ID=41219093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011526247A Expired - Fee Related JP5608653B2 (ja) 2008-09-04 2009-09-04 チュアブルな徐放性製剤

Country Status (8)

Country Link
US (1) US10668012B2 (enExample)
EP (1) EP2331076B1 (enExample)
JP (1) JP5608653B2 (enExample)
CN (1) CN102202654B (enExample)
AU (1) AU2009289464B2 (enExample)
CA (1) CA2736119C (enExample)
ES (1) ES2536736T3 (enExample)
WO (1) WO2010028290A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1400578B1 (it) 2010-06-18 2013-06-14 Alpex Pharma Sa Processo per la preparazione di compresse a rilascio controllato.
JP2015500241A (ja) * 2011-12-02 2015-01-05 ペガサス ラボラトリーズ インコーポレイテッド 両親媒性脂質をベースとする徐放性組成物
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions
EP2846773A4 (en) 2012-05-10 2015-12-30 Painreform Ltd DEPOT FORMULATIONS OF A LOCAL ANESTHETICS AND METHOD FOR THE MANUFACTURE THEREOF
CN103686676A (zh) * 2012-08-31 2014-03-26 中兴通讯股份有限公司 设备到设备通信系统的通信方法、装置及系统
US20140080908A1 (en) * 2012-09-19 2014-03-20 Phyto Tech Corp. Compositions and methods for improving or preventing depression-like symptoms
EP2968569A4 (en) 2013-03-15 2016-11-02 Argenta Mfg Ltd COUGAR FORMULATION
CA3017797A1 (en) 2016-03-17 2017-09-21 Thiogenesis Therapeutics, Inc. Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
JP6800596B2 (ja) * 2016-03-29 2020-12-16 小林製薬株式会社 錠剤
EP3519812B1 (en) * 2016-09-27 2026-05-06 Zolentroff, William C. Ala and salt formulation
CA3049952A1 (en) * 2017-07-26 2019-01-31 Tgx Soft Chew, Llc Starch-free soft chew for veterinary applications
CN109420163B (zh) * 2017-08-23 2022-06-21 中山市力恩普制药有限公司 治疗呼吸道感染的药物组合物及其制备方法和用途
CA3076392A1 (en) 2017-09-20 2019-03-28 Thiogenesis Therapeutics, Inc. Methods for the treatment of cysteamine sensitive disorders
WO2020136620A1 (en) * 2018-12-29 2020-07-02 3M Innovative Properties Company Oral articles and methods of use
CN113260351A (zh) * 2018-12-29 2021-08-13 3M创新有限公司 口腔制品及使用方法
CN111744018A (zh) * 2019-03-26 2020-10-09 北京福元医药股份有限公司 一种盐酸氨基葡萄糖药物制剂

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3567819A (en) * 1969-01-30 1971-03-02 Hoffmann La Roche Cold tablet
US5032406A (en) * 1989-02-21 1991-07-16 Norwich Eaton Pharmaceuticals, Inc. Dual-action tablet
GB8913889D0 (en) 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
US5182130A (en) * 1989-11-06 1993-01-26 Opta Food Ingredients, Inc. Method for producing an edible prolamine coating from an aqueous latex
US5077053A (en) * 1990-02-12 1991-12-31 Warner-Lambert Company Zein as a moisture barrier for sugarless edible compositions and method for preparing same
US5599556A (en) * 1991-12-31 1997-02-04 Abbott Laboratories Prolamine coatings for taste masking
US6210714B1 (en) * 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19630035A1 (de) 1996-07-25 1998-01-29 Asta Medica Ag Tramadol Multiple Unit Formulierungen
JP3877083B2 (ja) * 1996-08-03 2007-02-07 昭和産業株式会社 第４胃以降消化・吸収性反芻動物用飼料製剤並びにそれを含有する反芻動物用飼料
FR2752732B1 (fr) 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
ES2331442T3 (es) 1998-03-23 2010-01-04 General Mills, Inc. Encapsulacion de componentes en productos comestibles.
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
KR100889069B1 (ko) * 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
US6277409B1 (en) * 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
US20020106408A1 (en) * 2000-12-01 2002-08-08 Johnatan Bacon Prolamin-based sustained-release compositions and delayed-onset compositions
US6897205B2 (en) 2001-01-31 2005-05-24 Roehm Gmbh & Co. Kg Multi-particulate form of medicament, comprising at least two differently coated forms of pellet
US20030228368A1 (en) * 2001-09-28 2003-12-11 David Wynn Edible solid composition and dosage form
US7612112B2 (en) * 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US20060153908A1 (en) 2002-06-27 2006-07-13 Brian Strong Spherical pellet formulations
US7399488B2 (en) * 2002-07-05 2008-07-15 Collegium Pharmaceutical, Inc. Abuse-deterrent pharmaceutical compositions of opiods and other drugs
GB2403407B (en) 2003-07-03 2006-12-13 Michael Hilary Burke Palatable oral anthelmintic composition
JP2007509155A (ja) * 2003-10-21 2007-04-12 アルファーマ インコーポレイテッド クエチアピンを含有する薬剤
US20050089558A1 (en) 2003-10-28 2005-04-28 Alamo Pharmaceuticals, Llc Compositions and methods for the co-formulation and administration of tramadol and propoxyphene
JP5607291B2 (ja) * 2004-11-24 2014-10-15 メダ ファーマシューティカルズ インコーポレイテッド アゼラスチンを含む組成物およびその使用方法
WO2006082824A1 (ja) * 2005-02-03 2006-08-10 Nrl Pharma, Inc. マトリックス型腸溶性・徐放性組成物
JP4602949B2 (ja) * 2006-08-02 2010-12-22 和光堂株式会社 被覆粒子含有組成物及びその製造方法

Similar Documents

Publication Publication Date Title
JP2012502061A5 (enExample)
US20210113469A1 (en) Sustained release compositions using wax-like materials
CN102202654B (zh) 可咀嚼的缓释制剂
KR101476574B1 (ko) 서방성 하이드로코돈 제형
EP0785775B2 (en) Melt-extruded orally administrable opioid formulations
CN1942174B (zh) 微粒
KR100911779B1 (ko) 모다피닐을 포함하는 고형 제약 제제
TW200427448A (en) Controlled release preparations comprising tramadol and topiramate
CN103520130B (zh) 孟鲁斯特钠择时控释片及其制备方法
CN103520136B (zh) 孟鲁斯特钠脉冲胶囊及其制备方法
KR20090047310A (ko) 덱시부프로펜을 함유하는 다층정제
CN103222968A (zh) 一种含有氟尼辛葡甲胺的片剂及其制备方法
CN101537005B (zh) 可待因和氯苯那敏复方缓释胶囊
CN116350596A (zh) 利培酮速释缓释双释放制剂及其制备方法
HK1141441B (en) Sustained release pellets comprising wax-like material
JP2006089461A (ja) 覚醒剤原料含有レイアリング顆粒
HK1124265A (en) Stable pharmaceutical formulations containing escitalopram and bupropion